JNJ

[$$] Sales of Johnson & Johnson’s New Hepatitis C Drug Soar

[at The Wall Street Journal] – Sales of Johnson & Johnson’s new hepatitis C drug soared during its first full quarter on the market, in another sign of strong demand—and high prices—for a new generation of treatments for the liver-damaging … moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson […]

[video] Coca-Cola Shows Signs of a Rebound

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

Got Allergies? FDA to the Rescue

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

Arkansas AG asks court to reconsider drug ruling

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]

Tech stocks, once highfliers, drop; Nasdaq sinks

moreView todays social media effects on JNJView the latest stocks trending across Twitter. Click to view dashboardSee who Johnson is hiring next, click here to view […]